Evicenter
Linzess (linaclotide) in Irritable bowel syndrome with constipation
Manufacturer
AbbVie, Inc.; Ironwood Pharmaceuticals, Inc.
Prescribing information
Linzess (opens in a new tab)
Questions
19
Last updated

All questions

Guidelines: Linzess (linaclotide) in irritable bowel syndrome with constipation

1 question · 1 source

Guidelines

Do ACG (2021) and AGA (2022) guidelines recommend Linzess, a GC-C agonist, for adult IBS-C?

Applies to Irritable bowel syndrome with constipation (IBS-C) in adults

Note: The recommendation statement is the manufacturer's and cites the ACG clinical guideline (2021) and the AGA clinical practice guideline (2022). The captured page text does not quote either guideline's recommendation or state the grade each guideline assigned.